Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2026-01-01 @ 6:52 PM
Study NCT ID:
NCT02991456
Status:
COMPLETED
Last Update Posted:
2023-07-11
First Post:
2016-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and Temozolomide
Sponsor:
Duke University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-09
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-20
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-09
First Submit QC Date:
None
Study First Post Date:
2016-12-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-05-09
Results First Submit QC Date:
None
Results First Post Date:
2023-07-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-10
Last Update Post Date:
2023-07-11
Last Update Post Date Type:
ACTUAL